Speciality Medicines Financials

BSE: 544738

₹152.85

₹2.85 (1.90%)

As on 07-Sep-2026IST

Market cap

₹131 Cr

Revenue (TTM)

₹58 Cr

P/E Ratio

10

P/B Ratio

1.8

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	58.27	27.52	23.24	40.44	--	--
Total Income	58.54	27.66	23.26	40.45	--	--
Total Expenditure	49.14	22.25	19.66	38.16	--	--
EBITDA	9.13	5.27	3.58	2.28	--	--
Depreciation	0.20	0.23	0.30	0.11	--	--
EBIT	8.93	5.04	3.28	2.17	--	--
Interest	0.51	0.62	0.35	0.03	--	--
Other Income	0.27	0.13	0.02	0.00	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	8.69	4.56	2.95	2.14	--	--
Provision for Tax	0.08	1.62	1.26	0.66	--	--
Profit after Tax	8.61	2.93	1.69	1.48	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	30.42	15.06	5.87	1.93	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.77	0.86	1.16	0.01	--	--
Current Liabilities	6.80	6.71	6.21	3.83	--	--
Total Liabilities	39.98	22.68	13.26	5.78	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	3.56	1.69	1.90	2.23	--	--
Current Assets	36.42	20.94	11.34	3.55	--	--
Total Assets	39.98	22.68	13.26	5.78	--	--
Total Debt*	5.05	2.86	3.64	1.18	--	--
Net Current Assets	29.62	14.23	5.13	-0.28	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-5.79	-4.80	-4.21	0.81	--	--
Cash Flow from Investing Activities	-2.07	-0.03	0.03	-2.33	--	--
Cash from Financing Activities	8.46	4.81	4.37	1.60	--	--
Net Cash Inflow / Outflow	0.60	-0.01	0.18	0.08	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	13.38	5.73	4.42	4.70	--	--
Cash EPS (₹)	13.68	6.19	5.19	5.05	--	--
Adjusted Book Value (₹)	47.26	29.44	15.36	6.13	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-9.00	-9.38	-11.03	38.39	--	--
Free Cash Flow per Share (₹)	-10.91	-11.35	-13.89	-94.51	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	34.47	37.72	52.41	69.75	--	--
ROE (%)	37.85	28.03	43.30	76.56	--	--
ROA (%)	27.50	16.36	17.77	25.61	--	--
EBIT Margin (%)	15.33	18.31	14.12	5.36	--	--
Net Margin (%)	14.70	10.61	7.26	3.66	--	--
Cash Profit Margin (%)	15.11	11.50	8.54	3.93	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	111.71	18.43	-42.54	--	--	--
EBIT Growth (%)	77.20	53.55	51.42	--	--	--
Net Profit Growth (%)	193.43	73.70	14.16	--	--	--
EPS Growth (%)	133.30	29.68	-5.86	--	--	--
Book Value Growth (%)	101.92	156.66	203.73	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.13	1.43	2.00	0.57	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.17	0.19	0.62	0.61	--	--
Short term debt to equity ratio	0.04	0.11	0.29	0.61	--	--
Current Ratio	5.36	3.12	1.83	0.93	--	--
Quick Ratio	2.80	1.92	1.09	0.80	--	--
Interest Coverage	18.03	8.39	9.33	70.21	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	16.45	38.92	23.69	6.41	--	--
Asset Turnover	1.86	1.53	2.44	7.00	--	--
Receivable days	63.57	107.54	63.58	23.38	--	--
Inventory Days	79.57	83.72	39.87	4.35	--	--
Payable days	14.65	42.28	33.46	12.32	--	--
Cash Conversion Cycle	128.49	148.98	70.00	15.42	--	--